Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.
Researchers identified a 14-protein blood signature that may predict lung cancer years early, potentially enabling earlier ...
Researchers have identified a 14-protein blood signature that may predict lung cancer risk up to five years before diagnosis, ...
Man’s best friend may become cancer’s worst enemy.
Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...
A machine learning model developed by researchers at the Johns Hopkins Kimmel Cancer Center filters out the biological noise in liquid biopsy samples, helping clinicians better match therapies to ...
New patent expands globally protected IP estate beyond blood into alternative biofluids, positioning the Company's clinical mass spectrometry platform against traditional genomic liquid biopsies.
As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results